Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 20Breast Neoplasms 9Prostatic Neoplasms 6Stomach Neoplasms 5Carcinoma, Hepatocellular 5Melanoma 4Colorectal Neoplasms 4Multiple Pulmonary Nodules 3Head and Neck Neoplasms 3Disease 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Smoking Cessation 2Smoking 2Sarcopenia 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Neoplasms 2Liver Cirrhosis 2Gastrointestinal Neoplasms 2Anastomotic Leak 2Vasculitis 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Tobacco Use Cessation 1Tobacco Smoking 1Testicular Neoplasms 1Solitary Pulmonary Nodule 1

Interventions

gallium Ga 68 dotatate 1Tomography, X-Ray Computed 1Radionuclide Imaging 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Imaging 1Health Personnel 1Caregivers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cancer Diagnosis × Tomography, X-Ray Computed × Clear all
NCT03125629 2021-04-09

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Stanford University

Phase 2 Completed
53 enrolled 8 charts

Cancer Diagnosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡